2m 2m 2m 2m 2m 2m 2m
Genmab (GNMSF)
OTC
$355.00+$2.00 (+0.57%)
Price as of Sep 28, 2026- N/AMarket Cap
- 22.41%1-Year Change
- BiotechnologyIndustry
Genmab (GNMSF)
$355.00+$2.00 (+0.57%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$355.00
$355.00
$355.00
1-Year Range
$232.34
$355.00
$355.00
Latest Close$355.00
Change
+$2.00 (+0.56%)
Volume100
Information as of 09/28/2026
Company Profile
GENMAB A/S DKK
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
GENMAB A/S DKK
Key Executives
- Jan van de Winkel
- Rayne Waller
- Gregory David Emil Mueller
- Tahamtan Ahmadi
- Judith V. Klimovsky
Current Ownership Distribution
- Other55.4M (90.27%)
- Mutual Funds5.9M (9.69%)
- Institutions22,840 (0.04%)
- Insiders0 (0.00%)